Pulmonary Drug Delivery Systems Market: COVID 19 Impact and Recovery - Global Analysis, Size, Share, Trends, Business Strategies, Challenges, Growth Forecast 2021 to 2030
-
7847
-
Mar-21
-
150
-
PDF/PPT/Word
-
-
The Global Pulmonary Drug Delivery Systems Market 2021 – 2030 report we offer provides details and information regarding market revenue size or value, historical and forecast growth of the target market/industry, along with revenue share, latest developments, and ongoing trends, investment strategies, business developments, and investments, etc. The report also comprises subjective comprehensive research and is based on direct study and analysis of the quantitative and deep-dive data and information, which is further validated with an expert panel and /or through industry experts, players in the target market. Furthermore, the Global Pulmonary Drug Delivery Systems Market report covers various drivers, restraints, opportunities, and external threats till 2030. We also provide estimates on trading volume, information related to technological advancements, as well as updates on macroeconomic and governance factors.
Key Market Players included in the report:
GlaxoSmithKline plc
Merck & Co., Inc.
Sunovion Pharmaceuticals Inc.
Novartis AG
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim GmbH
Omron Healthcare, Inc.
Skyepharma Plc
CareFusion Corporation
Philips Respironics Inc.Various prominent players operating in the Global Pulmonary Drug Delivery Systems Market are focusing on the expansion of their business operations in emerging regions. In addition, companies in the Global Pulmonary Drug Delivery Systems Market are planning on strategies for product innovation and expansion of product portfolio by investments and mergers and acquisitions. An in-depth study on supply chain analysis presented in the report will give a better understanding of the Global Pulmonary Drug Delivery Systems Market.
However, in light of the recent COVID-19 outbreak, the operations of numerous industries have either been temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global Pulmonary Drug Delivery Systems market is no different, and this factor is anticipated to have a significantly negative impact on the revenue growth of this industry. Additionally, the high costs associated with the installation and maintenance of these machines is also a factor that may hamper the revenue growth of the global Pulmonary Drug Delivery Systems market over the course of this forecast period.
Segmentation on the basis of product:
Dry Powder Inhalers
Single-Dose Inhalers
Multi-Dose Inhaler
Metered Dose Inhaler
Manually-Actuated Pressurized Inhaler
Breath-Actuated Pressurized Inhaler
Nebulizers
Jet Nebulizers
Ultrasonic Wave Nebulizers
Vibrating Mesh Nebulizer
Segmentation on the basis of application:Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Cystic Fibrosis
Others (including cardiovascular disease, diabetes, respiratory therapy, and treatment of patients on ventilators)
Segmentation on the basis of distribution channel:Online
Retail pharmacy
Hospital pharmacyGlobal Pulmonary Drug Delivery Systems Market – by Region and Country
North America
US
CanadaEurope
Germany
UK
France
Russia
Spain
Italy
Rest of EuropeAsia Pacific
China
India
Japan
Australia
Rest of Asia PacificLatin America
Brazil
Mexico
Rest of Latin AmericaMiddle East & Africa
GCC
Israel
South Africa
Rest of Middle East & AfricaFor the Pulmonary Drug Delivery Systems research study, the following years have been considered to estimate the market size:
Actual Year: 2020
Estimated Year: 2021
Forecast Period: 2021–2030
Revenue in: US$
-
Chapter 1 Global Pulmonary Drug Delivery Systems Market Overview
1.1 Introduction
1.2 Taxonomy
1.2.1 By Type & End-Use
1.2.2 By Region
1.3 Drivers for Pulmonary Drug Delivery Systems
1.4 Restraints for Pulmonary Drug Delivery Systems
1.5 Opportunities for Pulmonary Drug Delivery Systems
1.6 Trends for Pulmonary Drug Delivery Systems
1.7 Macro-economic Factors
1.8 Regulatory Framework
1.9 Global Pulmonary Drug Delivery Systems Market Pricing Analysis by Region, 2021
1.10 Opportunity Map Analysis
1.11 Opportunity Orbits
1.12 Market Investment Feasibility Index
1.13 PEST Analysis
1.14 PORTER'S Five Force Analysis
1.15 Drivers & Restraints Impact Analysis
1.16 Marketing Strategy
1.17 Product Life Cycle Analysis
1.18 Industry Chain Analysis
1.19 Cost Structure Analysis
1.20 Covid-19 Impact Analysis
1.21 Regional Market Share and BPS Analysis in Pulmonary Drug Delivery Systems
Chapter 2 Global Pulmonary Drug Delivery Systems Market Overview
2.1 Global Pulmonary Drug Delivery Systems Market Value & Volume Comparison by Type (2014-2030)
2.2 Global Pulmonary Drug Delivery Systems Market by End-Use
2.3 Global Pulmonary Drug Delivery Systems Market Outlook by Region
2.4 Global Pulmonary Drug Delivery Systems Market Outlook (2014-2030)
2.5 Global Pulmonary Drug Delivery Systems Market Value & Volume by Regions
2.6 Global Pulmonary Drug Delivery Systems Market Value & Volume by Type
2.7 Global Pulmonary Drug Delivery Systems Market Value & Volume by End-Use
2.8 Global Pulmonary Drug Delivery Systems Market Y-o-Y Growth Rate Comparison 2015–2030
2.9 Global Pulmonary Drug Delivery Systems Market Share Comparison 2014–2030
Chapter 3 North America Pulmonary Drug Delivery Systems Market Overview
3.1 North America Pulmonary Drug Delivery Systems Market by Type
3.2 North America Pulmonary Drug Delivery Systems Market by End-Use
3.3 North America Pulmonary Drug Delivery Systems Market Outlook by Region
3.4 North America Pulmonary Drug Delivery Systems Market Outlook (2014-2030)
3.5 North America Pulmonary Drug Delivery Systems Market Value & Volume by Regions
3.6 North America Pulmonary Drug Delivery Systems Market Value & Volume by Type
3.7 North America Pulmonary Drug Delivery Systems Market Value & Volume by End-Use
3.8 North America Pulmonary Drug Delivery Systems Market Y-o-Y Growth Rate Comparison 2015–2030
3.9 North America Pulmonary Drug Delivery Systems Market Share Comparison 2014–2030
Chapter 4 Europe Pulmonary Drug Delivery Systems Market Overview
4.1 Europe Pulmonary Drug Delivery Systems Market by Type
4.2 Europe Pulmonary Drug Delivery Systems Market by End-Use
4.3 Europe Pulmonary Drug Delivery Systems Market Outlook by Region
4.4 Europe Pulmonary Drug Delivery Systems Market Outlook (2014-2030)
4.5 Europe Pulmonary Drug Delivery Systems Market Value & Volume by Regions
4.6 Europe Pulmonary Drug Delivery Systems Market Value & Volume by Type
4.7 Europe Pulmonary Drug Delivery Systems Market Value & Volume by End-Use
4.8 Europe Pulmonary Drug Delivery Systems Market Y-o-Y Growth Rate Comparison 2015–2030
4.9 Europe Pulmonary Drug Delivery Systems Market Share Comparison 2014–2030
Chapter 5 Asia-Pacific Pulmonary Drug Delivery Systems Market Overview
5.1 Asia-Pacific Pulmonary Drug Delivery Systems Market by Type
5.2 Asia-Pacific Pulmonary Drug Delivery Systems Market by End-Use
5.3 Asia-Pacific Pulmonary Drug Delivery Systems Market Outlook by Region
5.4 Asia-Pacific Pulmonary Drug Delivery Systems Market Outlook (2014-2030)
5.5 Asia-Pacific Pulmonary Drug Delivery Systems Market Value & Volume by Regions
5.6 Asia-Pacific Pulmonary Drug Delivery Systems Market Value & Volume by Type
5.7 Asia-Pacific Pulmonary Drug Delivery Systems Market Value & Volume by End-Use
5.8 Asia-Pacific Pulmonary Drug Delivery Systems Market Y-o-Y Growth Rate Comparison 2015–2030
5.9 Asia-Pacific Pulmonary Drug Delivery Systems Market Share Comparison 2014–2030
Chapter 6 South America Pulmonary Drug Delivery Systems Market Overview
6.1 South America Pulmonary Drug Delivery Systems Market by Type
6.2 South America Pulmonary Drug Delivery Systems Market by End-Use
6.3 South America Pulmonary Drug Delivery Systems Market Outlook by Region
6.4 South America Pulmonary Drug Delivery Systems Market Outlook (2014-2030)
6.5 South America Pulmonary Drug Delivery Systems Market Value & Volume by Regions
6.6 South America Pulmonary Drug Delivery Systems Market Value & Volume by Type
6.7 South America Pulmonary Drug Delivery Systems Market Value & Volume by End-Use
6.8 South America Pulmonary Drug Delivery Systems Market Y-o-Y Growth Rate Comparison 2015–2030
6.9 South America Pulmonary Drug Delivery Systems Market Share Comparison 2014–2030
Chapter 7 MEA Pulmonary Drug Delivery Systems Market Overview
7.1 MEA Pulmonary Drug Delivery Systems Market by Type
7.2 MEA Pulmonary Drug Delivery Systems Market by End-Use
7.3 MEA Pulmonary Drug Delivery Systems Market Outlook by Region
7.4 MEA Pulmonary Drug Delivery Systems Market Outlook (2014-2030)
7.5 MEA Pulmonary Drug Delivery Systems Market Value & Volume by Regions
7.6 MEA Pulmonary Drug Delivery Systems Market Value & Volume by Type
7.7 MEA Pulmonary Drug Delivery Systems Market Value & Volume by End-Use
7.8 MEA Pulmonary Drug Delivery Systems Market Y-o-Y Growth Rate Comparison 2015–2030
7.9 MEA Pulmonary Drug Delivery Systems Market Share Comparison 2014–2030
Chapter 8 Global Pulmonary Drug Delivery Systems Market Company Profiles
8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company1
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.2 Company2
8.4.3 Company3
8.4.4 Company4
8.4.5 Company5
8.4.6 Company6
8.4.7 Company7
8.4.8 Company8
8.4.9 Company9
8.4.10 Company10
8.4.11 Other Key Players
Chapter 9 Methodology and Data Source
9.1 Methodology/Research Approach
9.1.1 Market Size Estimation
9.2 Market Breakdown and Data Triangulation
9.3 Data Source
9.3.1 Secondary Sources
9.3.2 Primary Sources
9.4 Appendix
-
Inquiry Form
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
-
Request for Customization
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!